Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:18:39.800Z.
Calculation as of: 2026-10-06T18:18:39.800Z.
Quote observation: 2026-10-06T18:14:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4fd5d7af3ee6af72921bc315e5ba82b5757c441ca2a41ed9c1ba6c6f3afb8810
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Regencell Bioscience Holdings Limited
Market Cap
$3.85B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.96B
EV/EBIT Ratio
45.37x
TTM Avg
60.24x
3Y Avg
289.81x
5Y Avg
268.55x
Market Cap
$4.05B
EV/EBIT Ratio
N/A
TTM Avg
9.12x
3Y Avg
14.02x
5Y Avg
14.02x
Market Cap
$3.50B
EV/EBIT Ratio
N/A
TTM Avg
12.29x
3Y Avg
12.23x
5Y Avg
12.23x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.85B | N/A | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 45.37x | 60.24x | 289.81x | 268.55x |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.02B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | N/A | 9.12x | 14.02x | 14.02x |
| Veracyte, Inc. (VCYT)vs › | $3.57B | 34.56x | 84.60x | 100.14x | 100.14x |
| LivaNova PLC (LIVN)vs › | $4.15B | 20.07x | 18.41x | 129.51x | 140.01x |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | N/A | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | N/A | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.50B | N/A | 12.29x | 12.23x | 12.23x |
| Celcuity Inc. (CELC)vs › | $3.50B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
